OTCMKTS:AOXG Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis $0.0076 +0.00 (+1.33%) As of 05/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Aoxing Pharmaceutical Stock (OTCMKTS:AOXG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aoxing Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.0051▼$0.007650-Day Range$0.0062▼$0.0152-Week Range$0.0040▼$0.0178Volume788 shsAverage Volume68,400 shsMarket Capitalization$2.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.Read More… Receive AOXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aoxing Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address AOXG Stock News HeadlinesTeva Pharmaceutical Industries Limited (TEVA)April 20, 2024 | finance.yahoo.comAoxing Pharmaceutical Company, Inc. (AOXG)January 23, 2024 | finance.yahoo.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92% win rate trading system is built to profit in any market – whether Bitcoin is mooning, correcting, or chopping sideways. No more guessing. No more stress. Just precision trades that put you in control.May 7, 2025 | Crypto Swap Profits (Ad)Aoxing Pharmaceutical Co Inc AOXGDecember 16, 2023 | morningstar.comOPHLY Ono Pharmaceutical Co., Ltd.November 23, 2023 | seekingalpha.comAoxing Pharmaceutical Co (OTC:AOXG), Analyst Ratings, Price Targets, PredictionsJuly 13, 2022 | benzinga.comSee More Headlines AOXG Stock Analysis - Frequently Asked Questions How have AOXG shares performed this year? Aoxing Pharmaceutical's stock was trading at $0.0071 at the start of the year. Since then, AOXG shares have increased by 7.0% and is now trading at $0.0076. View the best growth stocks for 2025 here. How were Aoxing Pharmaceutical's earnings last quarter? Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) posted its quarterly earnings data on Monday, May, 16th. The company reported $0.01 EPS for the quarter. The firm had revenue of $6.56 million for the quarter. How do I buy shares of Aoxing Pharmaceutical? Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aoxing Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC) and Edap Tms (EDAP). Company Calendar Last Earnings5/16/2016Today5/07/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:AOXG Previous SymbolNYSEMKT:AXN CIKN/A Webaxzyen.icm.cn Phone(646) 367-1747Fax646-367-1747Employees350Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares381,209,000Free Float313,354,000Market Cap$2.90 million OptionableNot Optionable Beta7.22 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTCMKTS:AOXG) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aoxing Pharmaceutical Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aoxing Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.